Eon Challenges Pfizer's Patents For Zithromax

Law360, New York (January 24, 2005, 12:00 AM EST) -- Generic drug maker Eon Labs, Inc. has sued Pfizer, Inc. in New York federal court, seeking a declaratory judgment that a planned generic version of the antibiotic Zithromax does not infringe Pfizer’s patent for the drug.

The lawsuit, filed in the U.S. District for the Southern District of New York, argues that Eon’s version of the drug uses a different compound and is manufactured using a different method.

Last August, Eon filed several abbreviated new drug applications (ANDAs) with the U.S. Food and Drug Administration (FDA)...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.